Breakthrough Chemistry (BKTH) Stock Statistics & Valuation Metrics
Total Valuation
Breakthrough Chemistry has a market cap or net worth of $918.00K. The enterprise value is $2.64T.
- Market Cap
- $918.00K
- Enterprise Value
- $2.64T
Share Statistics
Breakthrough Chemistry has 10,431,759 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 10,431,759
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Breakthrough Chemistry’s return on equity (ROE) is 0.75 and return on invested capital (ROIC) is -6.59%.
- Return on Equity (ROE)
- 0.75
- Return on Assets (ROA)
- 0.62
- Return on Invested Capital (ROIC)
- -6.59%
- Return on Capital Employed (ROCE)
- -0.07
- Revenue Per Employee
- 5,025
- Profits Per Employee
- 480.87K
- Employee Count
- 3
- Asset Turnover
- 0.01
- Inventory Turnover
- 0.82
Valuation Ratios
The current PE Ratio of Breakthrough Chemistry is 2.44. Breakthrough Chemistry’s PEG ratio is 0.00.
- PE Ratio
- 2.44
- PS Ratio
- 48.72
- PB Ratio
- 1.02
- Price to FCF
- -65.31
- Price to Operating Cash Flow
- -65.30
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Breakthrough Chemistry had revenue of 15.07K and earned 1.44M in profits. Earnings per share was 0.15.
- Revenue
- 15.07K
- Gross Profit
- -25.27K
- Operating Income
- -145.30K
- Pretax Income
- 1.44M
- Net Income
- 1.44M
- EBITDA
- -107.21K
- Earnings Per Share (EPS)
- 0.15
Cash Flow
In the last 12 months, operating cash flow was -13.11K and capital expenditures 5, giving a free cash flow of -13.11K billion.
- Operating Cash Flow
- -13.11K
- Free Cash Flow
- -13.11K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Breakthrough Chemistry pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.53%
- Earnings Yield
- 44.21%
Stock Price Statistics
- Beta
- 2.05
- 52-Week Price Change
- -45.00%
- 50-Day Moving Average
- 0.14
- 200-Day Moving Average
- 0.18
- Relative Strength Index (RSI)
- 44.15
- Average Volume (3m)
- 26.63K
Financial Position
Breakthrough Chemistry as a current ratio of 6.17, with Debt / Equity ratio of 10.18%
- Current Ratio
- 6.17
- Quick Ratio
- 6.02
- Debt to Market Cap
- 0.50
- Net Debt to EBITDA
- -1.75
- Interest Coverage Ratio
- -411.62
Taxes
In the past 12 months, Breakthrough Chemistry has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Breakthrough Chemistry EV to EBITDA ratio is -8.08, with an EV/FCF ratio of -80.16.
- EV to Sales
- 59.80
- EV to EBITDA
- -8.08
- EV to Free Cash Flow
- -80.16
- EV to Operating Cash Flow
- -80.15
Balance Sheet
Breakthrough Chemistry has $1.91M in cash and marketable securities with $195.38K in debt, giving a net cash position of $1.71M billion.
- Cash & Marketable Securities
- $1.91M
- Total Debt
- $195.38K
- Net Cash
- $1.71M
- Net Cash Per Share
- $0.16
- Tangible Book Value Per Share
- $0.16
Margins
Gross margin is -80.23%, with operating margin of -893.01%, and net profit margin of 2153.62%.
- Gross Margin
- -80.23%
- Operating Margin
- -893.01%
- Pretax Margin
- 2153.62%
- Net Profit Margin
- 2153.62%
- EBITDA Margin
- -739.82%
- EBIT Margin
- -893.01%
Analyst Forecast
The average price target for Breakthrough Chemistry is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
